| Dr Elizabeth Acquista, MD | |
|
1725 New Hanover Medical Park Dr, Wilmington, NC 28403-5345 | |
| (910) 662-9300 | |
| (910) 662-2401 |
| Full Name | Dr Elizabeth Acquista |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | 1725 New Hanover Medical Park Dr, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639353022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0102X | Surgery - Surgical Critical Care | 201001217 (North Carolina) | Secondary |
| 208600000X | Surgery | 2010-01217 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
In the pandemic age of telehealth and new technologies, remote site lab or point-of-care (POC) testing of biofluids is a potentially rapid and non-invasive way to test for most diseases - including COVID-19.
Asthma is a serious, sometimes life-threatening respiratory disease that affects the quality of life for millions of people; but it can be managed if people know what it is and understand how the environment can affect asthma patients.
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. Though the rate has increased in recent years, the change has been slow and marginal.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | New Hanover Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952705519 PECOS PAC ID: 0143110460 Enrollment ID: O20141215000576 |
News Archive
In the pandemic age of telehealth and new technologies, remote site lab or point-of-care (POC) testing of biofluids is a potentially rapid and non-invasive way to test for most diseases - including COVID-19.
Asthma is a serious, sometimes life-threatening respiratory disease that affects the quality of life for millions of people; but it can be managed if people know what it is and understand how the environment can affect asthma patients.
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. Though the rate has increased in recent years, the change has been slow and marginal.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Novant Health New Hanover Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750978839 PECOS PAC ID: 7113330168 Enrollment ID: O20210112000621 |
News Archive
In the pandemic age of telehealth and new technologies, remote site lab or point-of-care (POC) testing of biofluids is a potentially rapid and non-invasive way to test for most diseases - including COVID-19.
Asthma is a serious, sometimes life-threatening respiratory disease that affects the quality of life for millions of people; but it can be managed if people know what it is and understand how the environment can affect asthma patients.
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. Though the rate has increased in recent years, the change has been slow and marginal.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
In the pandemic age of telehealth and new technologies, remote site lab or point-of-care (POC) testing of biofluids is a potentially rapid and non-invasive way to test for most diseases - including COVID-19.
Asthma is a serious, sometimes life-threatening respiratory disease that affects the quality of life for millions of people; but it can be managed if people know what it is and understand how the environment can affect asthma patients.
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. Though the rate has increased in recent years, the change has been slow and marginal.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Acquista, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: () - | Dr Elizabeth Acquista, MD 1725 New Hanover Medical Park Dr, Wilmington, NC 28403-5345 Ph: (910) 662-9300 |
News Archive
In the pandemic age of telehealth and new technologies, remote site lab or point-of-care (POC) testing of biofluids is a potentially rapid and non-invasive way to test for most diseases - including COVID-19.
Asthma is a serious, sometimes life-threatening respiratory disease that affects the quality of life for millions of people; but it can be managed if people know what it is and understand how the environment can affect asthma patients.
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. Though the rate has increased in recent years, the change has been slow and marginal.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 1 days ago
Dr. Gregory Gerard Bebb, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1414 Medical Center Dr, Wilmington, NC 28401 Phone: 910-763-7363 Fax: 910-251-8296 | |
Dr. Tor Martin Ljung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6752 Parker Farm Dr # 200, Wilmington, NC 28405 Phone: 910-341-3300 Fax: 910-341-3321 | |
Dr. F Alan Hubbard, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-763-6289 Fax: 910-251-1420 | |
Dr. Cyrus A Kotwall, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-343-0161 Fax: 910-772-9452 | |
Emily Fontenot Marcinkowski, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1414 Medical Center Dr, Wilmington, NC 28401 Phone: 910-763-7363 Fax: 910-251-8296 | |
Dr. Colston Arthur Edgerton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1725 New Hanover Medical Park Dr, Wilmington, NC 28403 Phone: 910-662-9300 Fax: 910-662-9301 | |
Dr. Joseph Minter Payne, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2221 S 17th St, Wilmington, NC 28401 Phone: 910-662-7720 Fax: 910-815-0840 |